导管消融与药物心率控制对老年持续性房颤合并射血分数降低心衰患者的随机对照研究
该随机对照研究纳入89例老年持续性房颤合并射血分数降低心衰患者,比较导管消融与药物心率控制的效果。12个月随访显示,消融组因心衰加重需非计划住院更少,LVEF改善更显著,窦性心律维持率更高。
要点
- 老年持续性房颤合并HFrEF患者,导管消融较药物心率控制可减少心衰加重非计划住院。
- 消融组12个月LVEF改善幅度显著优于药物组,NYHA心功能分级和房颤负荷也改善更明显。
- 消融组12个月窦性心律维持率51.1%,高于药物组的20.4%。
核心结论
- 在老年持续性房颤合并HFrEF患者中,导管消融与因心衰加重非计划住院风险更低相关,并改善LVEF和降低房颤负荷。
研究设计与样本
- 随机对照试验,共纳入89例老年持续性房颤合并HFrEF患者,平均年龄69.5±3.9岁,随机分为导管消融组(n=45)和药物心率控制组(n=44)。
主要发现
- 12个月随访时,导管消融组因心衰加重需非计划住院的发生率低于药物心率控制组(p=0.019)。
- 与基线相比,导管消融组NYHA心功能分级和房颤负荷的改善均优于药物心率控制组。
- 12个月随访时,导管消融组窦性心律维持率为51.1%,药物心率控制组为20.4%。
临床怎么用
- 对于老年持续性房颤合并HFrEF患者,在综合评估后可考虑导管消融以改善LVEF、降低房颤负荷并减少心衰加重住院。
局限性
- 本研究为小规模随机研究,样本量有限(共89例),结论需更大规模试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with heart failure with reduced ejection fraction (HFrEF) and atrial fibrillation are mostly elderly patients, and persistent atrial fibrillation (PerAF) with multiple comorbidities tends to have a worse clinical prognosis. However, there is a lack of randomised trial to investigate the impact of catheter ablation (CA) on outcomes in older PerAF combined with HFrEF. OBJECTIVE: This study aims to compare the effects of CA versus medical rate control (MRC) on severity indicators of HFrEF. METHODS: Older patients with PerAF and HFrEF underwent transthoracic echocardiography and were randomly assigned to receive either AF ablation or MRC. The primary outcome was changes in left ventricular ejection fraction (LVEF). RESULTS: A total of 89 patients (mean age 69.5±3.9 years) were randomly allocated to the CA group (n=45) and MRC group (n=44). Baseline characteristics were similar between the two groups. After 12 months, worsening heart failure requiring unplanned hospitalisation occurred less frequently in the CA group (p=0.019). In CA group, LVEF (from baseline 36.1%±2.7% to 48.9%±7.1%; p<0.00 L) improved higher compared with the MRC group (8.7 (5.9 to 11.5)), p<0.001. Compared with baseline, New York Heart Association functional class and AF burden also showed improvement in CA group than MR group. At a follow-up period of 12 months, sinus rhythm rate was higher in CA group than MRC group, 51.1% versus 20.4%. CONCLUSION: This limited small-scale randomised study showed that CA in older patients with PerAF and HFrEF was associated with a lower likelihood of unplanned hospitalisations due to worsening heart failure with improvement in LVEF and lower AF burden. TRIAL REGISTRATION NUMBER: NCT05827172.
引用
- Song, Wang, Qidong, et al. Catheter ablation versus medical rate control for persistent atrial fibrillation in older heart failure patients with reduced ejection fraction. Heart. 2025. PMID: 40393692. doi:10.1136/heartjnl-2024-324668
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。